Skip to content
WHAT IS TECHNOLOGY TRANSFER?
COVID-19 RESEARCH LICENSING
DO YOU BELIEVE YOU HAVE A NOVEL INVENTION?
FIND YOUR BUSINESS MANAGER
FOR PARTNER NHS STAFF
PROOF OF CONCEPT FUNDS
PORTICO VENTURES PROGRAMME
XIP: UCLB ONLINE LICENSING
News from UCLB
Subscribe to our RSS News feed
Apollo Therapeutics News
AVATAR project receives £3.37 m to systemically evaluate its therapy to help those with auditory hallucinations
28th October 2020
A team of researchers will be extending the evaluation of the unique AVATAR therapy and assessing the feasibility of making ...
Top US, UK, and EU universities working together to help economies fuel post-COVID recovery
18th September 2020
Ten world-leading US, UK, and EU universities will discuss with leaders in national governments and funding bodies on how to ...
Odin Vision receives NIHR funding to accelerate its AI technology for patient benefit
8th September 2020
NIHR (National Institute for Health Research) has recognised Odin Vision as one of the companies to benefit from its new ...
Freeline announces pricing of initial public offering
10th August 2020
Freeline Therapeutics has announced the pricing of its initial public offering in the United States of 8,823,529 American Depositary Shares ...
Bramble energy secures significant new capital to accelerate its unique fuel cell deployment
4th August 2020
Bramble Energy, the world’s most scalable hydrogen fuel cell company has raised a £5m Series A round. BGF led the ...
UCL Technology Fund announces first close of £100m Fund 2
3rd August 2020
UCL Technology Fund (UCLTF), managed by AlbionVC in collaboration with UCL Business (UCLB) (the university’s commercialisation company and part of ...
Humanloop raises funding to teach AI to learn from humans faster
29th July 2020
Humanloop, a game changing UCL spinout, has attracted investment from UCL’s Technology Fund (UCLTF). Based on the world-leading research of ...
UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S. healthcare investment firm
21st July 2020
Apollo Therapeutics News
UCL Business (UCLB) and Apollo Therapeutics (Apollo), a pioneering collaboration between three global pharmaceutical companies and three UK university technology ...
Research England backs two initiatives to boost economic value realised from university research
16th July 2020
Research England has awarded two grants, totalling £1.5 million, to support two programmes working to dramatically increase the economic value ...
UCLB spinout Freeline Closes $120 Million Series C Financing Round
1st July 2020
Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, announced the closing of a $120 ...
UCL Business wins in the KE Awards 2020
25th June 2020
LONDON – 25th June 2020 – UCL Business (UCLB) has won the Knowledge Exchange External Initiative of the Year in ...
UCLTF supports UCL cancer antibody therapies for Covid-19
18th June 2020
UCL Technology Fund (UCLTF), managed by AlbionVC in collaboration with UCL Business (UCLB), has funded UCL’s Cancer Institute in repurposing ...
Achilles Therapeutics doses first patient in Phase I/II Study in recurrent or metastatic malignant melanoma with first TIL therapy to specifically target clonal neoantigens
2nd June 2020
Achilles Therapeutics was formed in October 2016 by Syncona Ltd and Cancer Research Technology, with the support of UCLB and ...
Orchard Therapeutics Announces First Patient Dosed with OTL-201 Gene Therapy in Proof-of-Concept Clinical Trial for Sanfilippo Syndrome (MPS-IIIA)
28th April 2020
BOSTON and LONDON, April 27, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the first patient has been ...
UCL supports worldwide dissemination of free-to-access manufacturing instructions for COVID-19 breathing aids
7th April 2020
Governments across the world, healthcare providers and device manufacturers can now request a free of charge licence to the design ...
Load more stories
Find out more
Go to Top